Mechanisms of platinum drug resistance

Trends in Pharmacological Sciences

Volumn 26, Issue 3, 2005, Pages 113-116

  Ohmichi, Masahide ^a   Hayakawa, Jun ^a   Tasaka, Keiichi ^a   Kurachi, Hirohisa ^b   Murata, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATINUM; PROTEIN KINASE B;

APOPTOSIS; CYTOTOXICITY; DNA DAMAGE; DRUG BIOAVAILABILITY; DRUG MECHANISM; PRIORITY JOURNAL; REVIEW;

EID: 14644440586     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.01.002     Document Type: Short Survey

References (25)

1. Z. Siddik Cisplatin: mode of cytotoxic action and molecular basis of resistance Oncogene 22 2003 7265 7279
2. M.M. Gottesman Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2 2002 48 58
3. L.R. Kelland Preclinical perspectives on platinum resistance Drugs 59 2000 1 8
4. M.A. Fuertes Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance Chem. Rev. 103 2003 645 662
5. X.L. Liang Mislocalization of membrane proteins associated with multidrug resistance in CP-r cancer cell lines Cancer Res. 63 2003 5909 5916
6. 14C]carboplatin- binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines Mol. Pharmacol. 66 2004 789 793
7. K. Katano Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper Cancer Res. 62 2002 6559 6565
8. A.K. Holzer The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells Mol. Pharmacol. 66 2004 817 823
9. W. Dempke Cisplatin resistance and oncogenes-a review Anticancer Drugs 11 2000 225 236
10. T. Wada, and J.M. Penninger Mitogen-activated protein kinases in apoptosis regulation Oncogene 23 2004 2838 2849
11. J. Hayakawa Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line J. Biol. Chem. 274 1999 31648 31654
12. J. Hayakawa Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation by genotoxic stress Mol. Cell 16 2004 521 535
13. T.F. Franke PI3K/Akt and apoptosis: size matters Oncogene 22 2003 8983 8998
14. J.Y. Yang Surviving the kiss of death Biochem. Pharmacol. 68 2004 1027 1031
15. S.R. Datta Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis Dev. Cell 3 2002 631 643
16. J. Downward PI 3-kinase, Akt and cell survival Semin. Cell Dev. Biol. 15 2004 177 182
17. S. Mabuchi Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel J. Biol. Chem. 277 2002 33490 33500
18. J. Hayakawa Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin Cancer Res. 60 2000 5988 5994
19. H. Tran DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein Science 296 2002 530 534
20. E. Arimoto-Ishida Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin Endocrinology 145 2004 2014 2022
21. R.Z. Orlowski, and A.S. Baldwin Jr NF-kappaB as a therapeutic target in cancer Trends Mol. Med. 8 2002 385 389
22. S. Mabuchi Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models J. Biol. Chem. 279 2004 23477 23485
23. J.Q. Cheng Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway Drug Resist. Updat. 5 2002 131 146
24. C.S. Mitsiades The Akt pathway: molecular targets for anti-cancer drug development Curr. Cancer Drug Targets 4 2004 235 256
25. INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin Oncogene 23 2004 201 212